Answers are grounded in this paper and cite their sources.
Current evidence indicates no significant benefit of ALT over standard land-based care for improving lymphedema status or physical function in people with UL lymphedema. Patient preference should guide the choice of care to facilitate adherence. Further research is required to strengthen the evidence from four studies in people with UL lymphedema, and to establish the efficacy of this intervention in people with lower limb lymphedema. Review registration: PROSPERO (CRD42015019900).
No takes yet. Share an insight, caveat, or question.
Yeung et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: